Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Sol Gel Technologies Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sol Gel Technologies Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash from Operating Activities
-$17m
CAGR 3-Years
14%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Operating Activities
$1.2B
CAGR 3-Years
37%
CAGR 5-Years
12%
CAGR 10-Years
-10%
I
InterCure Ltd
TASE:INCR
Cash from Operating Activities
-â‚Ş53.6m
CAGR 3-Years
N/A
CAGR 5-Years
-105%
CAGR 10-Years
-32%
Mediwound Ltd
NASDAQ:MDWD
Cash from Operating Activities
-$14.1m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
0%
S
Seach Medical Group Ltd
TASE:SEMG
Cash from Operating Activities
-â‚Ş3.8m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Operating Activities
â‚Ş24.1m
CAGR 3-Years
101%
CAGR 5-Years
-9%
CAGR 10-Years
20%
No Stocks Found

Sol Gel Technologies Ltd
Glance View

Market Cap
14.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
0.721 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Sol Gel Technologies Ltd's Cash from Operating Activities?
Cash from Operating Activities
-17m USD

Based on the financial report for Sep 30, 2024, Sol Gel Technologies Ltd's Cash from Operating Activities amounts to -17m USD.

What is Sol Gel Technologies Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-30%

Over the last year, the Cash from Operating Activities growth was -51%. The average annual Cash from Operating Activities growth rates for Sol Gel Technologies Ltd have been 14% over the past three years , -30% over the past five years .

Back to Top